BDBM518966 3-[2-(cis-4-tert-butylcyclohexyl)-1H-benzimidazol-1-yl]-N-[(1R,2R,4R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl]propanamide::US11141403, Example 33

SMILES CC(C)(C)[C@@H]1CC[C@@H](CC1)c1nc2ccccc2n1CCC(=O)N[C@@H]1C[C@H]2CC[C@]1(C)C2(C)C

InChI Key InChIKey=IMDMPVOUPGLWFE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 518966   

TargetN-acetylglucosamine-1-phosphotransferase subunits alpha/beta(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM518966(US11141403, Example 33 | 3-[2-(cis-4-tert-butylcyc...)
Affinity DataIC50: 60nMAssay Description:The TarO biochemical enzymatic assay is a liquid chromatography-mass spectroscopy (LC-MS) based end point assay that measures C55-P-P-GlcNAc (LIPID I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/4/2022
Entry Details
Go to US Patent